FLUTIFORM® (Formoterol fumarate / Fluticasone propionate)

DRUG2 trials

Sponsors

Mundipharma Research Limited

Conditions

AsthmaAsthma Bronchiale

Phase 3

Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma

CompletedNCT00476073

Mundipharma Research LimitedAsthma Bronchiale

Start: 2007-04-30End: 2008-01-31Updated: 2018-10-24

Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma

CompletedNCT00475813

Mundipharma Research LimitedAsthma

Start: 2007-03-31End: 2008-02-29Updated: 2018-10-24